All published articles of this journal are available on ScienceDirect.

RESEARCH ARTICLE

Cannabis and Tinnitus in People with and without HIV

Chukwuemeka N. Okafor1 , * Open Modal Deanna Ware2 Andrew Edmonds3 Anjali Sharma4 Deborah Gustafson5 Cecile D. Lahiri6 Todd T. Brown7 Gayle Springer8 Peter Torre III9 Allison G Abraham10 Howard J. Hoffman11 Mirjam-Colette Kempf12 Phyllis Tien13 Bradley E. Aouizerat14 Valentina Stosor15 Ken Ho16 Deborah L. Jones17 Kathleen M. Weber18 Kara W. Chew19 Ducel Jean-Berluche20 Michael Plankey2 Authors Info & Affiliations
The Open AIDS Journal 20 Aug 2026 RESEARCH ARTICLE DOI: 10.2174/0118746136457303260813073100

Abstract

Introduction/Objective

The relationship between cannabis use and tinnitus is unclear, particularly among people with HIV. The relationship between cannabis use and tinnitus prevalence and its severity in the MACS/WIHS Combined Cohort Study (MWCCS) was examined.

Methods

Cross-sectional data collected between October 1, 2020, and September 30, 2022, were drawn from the MWCCS. Tinnitus was defined as bothersome ringing, roaring, or buzzing in the ears or head that lasted for 5 minutes or more in the past 12 months. Tinnitus severity (among those reporting tinnitus) was dichotomized as no/small problem versus moderate to very big problem. Cannabis use was self-reported as the frequency of use in the past six months. Modified Poisson regression models were used to estimate associations adjusted for age, sex, race/ethnicity, HIV status, loud noise exposure, self-rated hearing, smoking, depression, as well as HIV viral load suppression and years of nucleoside reverse transcriptase inhibitors medication use (only for those with HIV).

Results

Among 3,437 participants (mean age=55; 55% female; 63% PWH), 31% reported cannabis use and 16% reported tinnitus. There was no statistically significant association between cannabis use and tinnitus prevalence. However, any cannabis use was significantly associated with a 29% lower prevalence of reporting moderate-to-severe tinnitus severity (aPR=0.71; 95% CI: 0.54–0.94). Stratified analyses also showed that any cannabis use was associated with a lower prevalence of reporting moderate-to-severe tinnitus severity (aPR=0.58; 95% CI: 0.37–0.90) among persons without HIV.

Discussion

Cannabis use was not associated with tinnitus prevalence but was associated with lower perceived tinnitus severity, particularly among participants without HIV. These findings suggest that cannabis may influence the subjective burden of tinnitus rather than its occurrence, although the underlying mechanisms remain unclear and may involve factors such as symptom perception or coping.

Conclusion

In this large cohort, cannabis use was not associated with the presence of tinnitus but was associated with lower reported tinnitus severity. Given the cross-sectional design and potential for residual confounding, these findings should be considered hypothesis-generating and warrant confirmation in longitudinal studies.

Keywords: Tinnitus, cannabis use, HIV, Tinnitus severity, MACS/WIHS combined cohort study, Epidemiology of hearing disorders.
Fulltext HTML PDF
1800
1801
1802
1803
1804